Teleflex (NYSE: TFX) reported Q1 EPS of $1.80, $0.11 better than the analyst estimate of $1.69. Revenue for the quarter came in at $487.9 million versus the consensus estimate of $472.69 million.

GUIDANCE:

Teleflex sees FY2017 EPS of $8.05-$8.23, versus the consensus of $8.10.

• On a GAAP basis, revenues in 2017 are expected to increase 10.0% to 11.5% over the prior year, reflecting the anticipated 2.5% unfavorable impact of foreign currency exchange rate fluctuations. On a constant currency basis, the Company estimates that revenues for full year 2017 will increase 12.5% to 14.0%. The forecasted revenue growth includes the impact of Vascular Solutions' product sales, which are expected to contribute approximately 8.5% to 9.0% to our revenue growth on a GAAP and constant currency basis

For earnings history and earnings-related data on Teleflex (TFX) click here.